Compugen Ltd. Stock TEL AVIV STOCK EXCHANGE
Equities
CGEN
IL0010852080
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
763.4 ILa | +1.85% | +3.69% | +10.96% |
Mar. 08 | Truist Securities Adjusts Price Target on Compugen to $5 From $4, Maintains Buy Rating | MT |
Mar. 05 | Transcript : Compugen Ltd., Q4 2023 Earnings Call, Mar 05, 2024 |
Sales 2024 * | 37.9M 14.43B | Sales 2025 * | 35.29M 13.44B | Capitalization | 170M 64.77B |
---|---|---|---|---|---|
Net income 2024 * | -13M -4.95B | Net income 2025 * | -29M -11.04B | EV / Sales 2024 * | 4.49 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 4.82 x |
P/E ratio 2024 * |
-14.6
x | P/E ratio 2025 * |
-7.04
x | Employees | 68 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.62% |
Latest transcript on Compugen Ltd.
1 day | +1.85% | ||
1 week | +3.69% | ||
Current month | -18.20% | ||
1 month | -18.84% | ||
3 months | +8.50% | ||
6 months | +158.52% | ||
Current year | +10.96% |
Managers | Title | Age | Since |
---|---|---|---|
Anat Cohen-Dayag
CEO | Chief Executive Officer | 57 | 01-12-31 |
Alberto Sessa
DFI | Director of Finance/CFO | 61 | 22-10-31 |
Eran Ophir
CTO | Chief Tech/Sci/R&D Officer | - | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Sekhri
CHM | Chairman | 66 | 17-10-01 |
Sanford Zweifach
BRD | Director/Board Member | 68 | 18-06-10 |
Gilead Halevy
BRD | Director/Board Member | 57 | 18-06-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 763.4 | +1.85% | 76,116 |
24-04-24 | 749.5 | +4.58% | 53,478 |
24-04-21 | 716.7 | -2.65% | 38,542 |
24-04-18 | 736.2 | -0.51% | 118,012 |
24-04-17 | 740 | +0.61% | 86,262 |
Delayed Quote TEL AVIV STOCK EXCHANGE, April 25, 2024 at 07:24 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.94% | 42.59B | |
+8.35% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.82% | 24.81B | |
-24.19% | 18.17B | |
+28.83% | 12.05B | |
-2.99% | 11.7B | |
+6.99% | 11.1B |
- Stock Market
- Equities
- CGEN Stock
- CGEN Stock